We developed a machine learning model to quantify cardiac fibrosis (which is associated with cardiovascular disease) using cardiac MRI data from 41,505 UK Biobank participants. In the subsequent large-scale GWAS of cardiac fibrosis, we identified 11 independent genomic loci, 9 of which were implicated in in vitro cardiac fibroblast activation.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
López, B. et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat. Rev. Cardiol. 18, 479–498 (2021). A comprehensive review article on the mechanisms, diagnosis and therapeutic approaches for diffuse myocardial fibrosis.
Tam, V. et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet. 20, 467–484 (2019). A review article that critically appraises the strengths and limitations of GWAS.
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018). A review article that describes the UK Biobank recruitment protocol and the deep phenotyping of study participants.
Diao, K. et al. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J. Cardiovasc. Magn. Reson. 18, 92 (2017). A meta-analysis providing evidence validating the use of non-invasive T1 mapping as a surrogate for histological assessment of myocardial fibrosis.
Treibel, T. A. et al. Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1. JACC Cardiovasc. Imaging 13, 44–54 (2020). This paper presents evidence supporting the use of extracellular volume fraction for MRI-based fibrosis quantification as a more sensitive marker with stronger associations with disease than T1 time.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Nauffal, V. et al. Genetics of myocardial interstitial fibrosis in the human heart and association with disease. Nat. Genet. https://doi.org/10.1038/s41588-023-01371-5 (2023).
Rights and permissions
About this article
Cite this article
Machine learning to examine the genetic underpinnings of cardiac fibrosis at scale. Nat Genet 55, 736–737 (2023). https://doi.org/10.1038/s41588-023-01369-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-023-01369-z
